Skip to main content
. 2020 Apr 23;11:603. doi: 10.3389/fmicb.2020.00603

FIGURE 2.

FIGURE 2

Effect of Retro-1 analogs on early stages of VACV infection. (A) Schematic representation of VACV entry assay. (B) Relative light units (RLUs) in the presence of select retrograde inhibitors diluted to 2.5 μM (light gray), 5 μM (dark gray), and 10 μM (black). Values plotted represent the average of two independent experiments.